These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 14534913

  • 21. No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study.
    Restemeyer C, Weiller C, Liepert J.
    Restor Neurol Neurosci; 2007; 25(2):143-50. PubMed ID: 17726273
    [Abstract] [Full Text] [Related]

  • 22. Levodopa-induced striatal activation in Parkinson's disease: a functional MRI study.
    Kraft E, Loichinger W, Diepers M, Lule D, Schwarz J, Ludolph AC, Storch A.
    Parkinsonism Relat Disord; 2009 Sep; 15(8):558-63. PubMed ID: 19467909
    [Abstract] [Full Text] [Related]

  • 23. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease.
    Nausieda PA, Pfeiffer RF, Tagliati M, Kastenholz KV, DeRoche C, Slevin JT.
    Clin Ther; 2005 Jan; 27(1):58-63. PubMed ID: 15763606
    [Abstract] [Full Text] [Related]

  • 24. Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
    Hauser RA, Holford NH.
    Mov Disord; 2002 Sep; 17(5):961-8. PubMed ID: 12360545
    [Abstract] [Full Text] [Related]

  • 25. Effect of dopamine agonists on fatigue and somnolence in Parkinson's disease.
    Oved D, Ziv I, Treves TA, Paleacu D, Melamed E, Djaldetti R.
    Mov Disord; 2006 Aug; 21(8):1257-61. PubMed ID: 16685690
    [Abstract] [Full Text] [Related]

  • 26. The beneficial effects of subthalamic nucleus stimulation on manipulative finger force control in Parkinson's disease.
    Nowak DA, Topka H, Tisch S, Hariz M, Limousin P, Rothwell JC.
    Exp Neurol; 2005 Jun; 193(2):427-36. PubMed ID: 15869945
    [Abstract] [Full Text] [Related]

  • 27. Conversion to controlled-release levodopa/carbidopa treatment and quality of life as measured by the Nottingham Health Profile. The STAR Study Group.
    Martínez-Martín P, Grandas F, Linazasoro G, Bravo JL.
    Neurologia; 1999 Jun; 14(7):338-43. PubMed ID: 10570620
    [Abstract] [Full Text] [Related]

  • 28. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [Abstract] [Full Text] [Related]

  • 29. The effects of levodopa on tongue strength and endurance in patients with Parkinson's disease.
    De Letter M, Santens P, Van Borsel J.
    Acta Neurol Belg; 2003 Mar; 103(1):35-8. PubMed ID: 12704981
    [Abstract] [Full Text] [Related]

  • 30. A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations.
    Blindauer K, Shoulson I, Oakes D, Kieburtz K, Schwid S, Fahn S, Stern M, Goetz C, Nutt J, Goren S, Sayag N, Scolnik M, Levy R, Eyal E, Salzman P, Pagano M, Parkinson Study Group.
    Arch Neurol; 2006 Feb; 63(2):210-6. PubMed ID: 16476809
    [Abstract] [Full Text] [Related]

  • 31. Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulation.
    Rodrigues JP, Walters SE, Stell R, Mastaglia FL, Thickbroom GW.
    Neurosci Lett; 2008 Dec 19; 448(1):29-32. PubMed ID: 18952149
    [Abstract] [Full Text] [Related]

  • 32. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up].
    Salazar Tortolero G, Wix Ramos R, Salazar Aladrén P, Jiménez León JC.
    Rev Neurol; 2008 Dec 19; 38(8):715-9. PubMed ID: 15122540
    [Abstract] [Full Text] [Related]

  • 33. Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
    Goetz CG, Damier P, Hicking C, Laska E, Müller T, Olanow CW, Rascol O, Russ H.
    Mov Disord; 2007 Jan 15; 22(2):179-86. PubMed ID: 17094088
    [Abstract] [Full Text] [Related]

  • 34. Intravenous flumazenil for Parkinson's disease: a single dose, double blind, placebo controlled, cross-over trial.
    Ondo WG, Silay YS.
    Mov Disord; 2006 Oct 15; 21(10):1614-7. PubMed ID: 16830315
    [Abstract] [Full Text] [Related]

  • 35. Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study.
    Mizuno Y, Abe T, Hasegawa K, Kuno S, Kondo T, Yamamoto M, Nakashima M, Kanazawa I, STRONG Study Group.
    Mov Disord; 2007 Oct 15; 22(13):1860-5. PubMed ID: 17618525
    [Abstract] [Full Text] [Related]

  • 36. Quantitative measurements of alternating finger tapping in Parkinson's disease correlate with UPDRS motor disability and reveal the improvement in fine motor control from medication and deep brain stimulation.
    Taylor Tavares AL, Jefferis GS, Koop M, Hill BC, Hastie T, Heit G, Bronte-Stewart HM.
    Mov Disord; 2005 Oct 15; 20(10):1286-98. PubMed ID: 16001401
    [Abstract] [Full Text] [Related]

  • 37. Levodopa-induced modulation of subthalamic beta oscillations during self-paced movements in patients with Parkinson's disease.
    Doyle LM, Kühn AA, Hariz M, Kupsch A, Schneider GH, Brown P.
    Eur J Neurosci; 2005 Mar 15; 21(5):1403-12. PubMed ID: 15813950
    [Abstract] [Full Text] [Related]

  • 38. Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms.
    Doan JB, Melvin KG, Whishaw IQ, Suchowersky O.
    Behav Brain Res; 2008 Dec 12; 194(2):207-13. PubMed ID: 18692094
    [Abstract] [Full Text] [Related]

  • 39. Hand coordination as a quantitative measure of motor abnormality and therapeutic response in Parkinson's disease.
    Benice TS, Lou JS, Eaton R, Nutt J.
    Clin Neurophysiol; 2007 Aug 12; 118(8):1776-84. PubMed ID: 17576094
    [Abstract] [Full Text] [Related]

  • 40. Amantadine reduces the duration of levodopa-induced dyskinesia: a randomized, double-blind, placebo-controlled study.
    da Silva-Júnior FP, Braga-Neto P, Sueli Monte F, de Bruin VM.
    Parkinsonism Relat Disord; 2005 Nov 12; 11(7):449-52. PubMed ID: 16154788
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.